5744-51-4

Basic information

• Product Name: ETHYL 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBOXYLATE
• Synonyms: 1H-Pyrazole-3-carboxylic acid, 1,5-dimethyl-, ethyl ester;1,5-DIMETHYL-1 H-PYRAZOLE-3-CARBOXYLIC ACID ETHYL ESTER;AKOS B006684;AKOS PAO-0796;BUTTPARK 90\11-93;ETHYL 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBOXYLATE;ART-CHEM-BB B006684;VITAS-BB TBB000644
• CAS NO: 5744-51-4
• Molecular Formula: C₈H₁₂N₂O₂
• Molecular Weight: 168.19
• Mol File: 5744-51-4.mol
• Article Data: 15

Chemical Properties

• Melting Point: 39-41°C
• Boiling Point: 154°C 10mm
• Flash Point: 110.3±21.8℃
• Appearance: /
• Density: 1.12±0.1 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 0.0135mmHg at 25°C
• Refractive Index: 1.521
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 0.54±0.10(Predicted)
• CAS DataBase Reference: ETHYL 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBOXYLATE(5744-51-4)
• EPA Substance Registry System: ETHYL 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBOXYLATE(5744-51-4)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 36/37/38-22
• Safety Statements: 26-36/37/39
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 5744-51-4(Hazardous Substances Data)

Usage

Chemical Properties

White to light yellow solid

InChI:InChI=1/C8H12N2O2/c1-4-12-8(11)7-5-6(2)10(3)9-7/h5H,4H2,1-3H3

Upstream product

• 615-79-2 ethyl 2,4-diketopentanoate 
• 456-48-4 3-Fluorobenzaldehyde 
• 60-34-4 methylhydrazine 
• 4027-57-0 ethyl 5-methyl-2H-pyrazole-3-carboxylate 
• 77-78-1 dimethyl sulfate 
• 4027-57-0 ethyl 5-methyl-1H-pyrazole-3-carboxylate 
• 74-88-4 methyl iodide 
• 623-47-2 propynoic acid ethyl ester 
• 907178-33-0 (E)-2-(N-methoxy-N-methyl-amino)-4-oxo-2-pentenoic acid ethyl ester 
• 98790-58-0 ethyl (Z)-4-hydroxy-2-oxopent-3-enoate 
• 64-17-5 ethanol 
• 7339-53-9 methyl hydrazine hydrochloride 
• 135351-18-7 (E)-1,1,1-trichloro-4-methoxypent-3-en-2-one 

Downstream Products

• 81153-54-0 6-[m-(1,5-dimethylpyrazole-3-carboxamido)phenyl]-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole 
• 1269438-98-3 (1S,3S,7S,10R,11S,12S,16S)-3-((E)-1-(1,5-dimethyl-1H-pyrazol-3-yl)prop-1-en-2-yl)-8,8,10,12,16-pentamethyl-7,11-bis(trimethylsilyloxy)-4-oxabicyclo[14.1.0]heptadecane-5,9-dione 
• 1269438-94-9 tributyl((1,5-dimethyl-1H-pyrazol-3-yl)methyl)phosphonium chloride 
• 180519-09-9 3-(chloromethyl)-1-methyl-5-methylpyrazole 
• 1293488-06-8 2-[(1,5-dimethyl)pyrazol-3-yl]propan-2-ol 
• 25016-15-3 1-(1,5-dimethyl-1H-pyrazol-3-yl)ethan-1-one 
• 824431-19-8 2-[bis(1,5-dimethyl-1H-pyrazol-3-ylmethyl)amino]ethan-1-ol 
• 1373247-81-4 ethyl 4-iodo-1,5-dimethyl-1H-pyrazole-3-carboxylate 
• 1073065-21-0 7-(3-((4-(4-acetylpiperazin-1-yl)phenoxy)methyl)-1,5-dimethyl-1H-pyrazol-4-yl)-3-(3-(naphthalen-1-yloxy)propyl)-1-(pyridin-3-ylmethyl)-1H-indole-2-carboxylic acid 

Relevant articles and documents

Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10)

Soluble adenylyl cyclase (sAC) has gained attention as a potential therapeutic target given the role of this enzyme in intracellular signaling. We describe successful efforts to design improved sAC inhibitors amenable for in vivo interrogation of sAC inhibition to assess its potential therapeutic applications. This work culminated in the identification of TDI-10229 (12), which displays nanomolar inhibition of sAC in both biochemical and cellular assays and exhibits mouse pharmacokinetic properties sufficient to warrant its use as an in vivo tool compound.

PYRAZOLE DERIVATIVES AS H4 ANTAGONIST COMPOUNDS

The disclosures herein relate to novel compounds of formula (1): and salts thereof, wherein A; X;n; R1 and R2 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with H4 receptors.

Pyrazole functionalized n-heterocyclic carbene ruthenium compound with anticancer activity and preparation method and application thereof

The invention discloses a pyrazole functionalized n-heterocyclic carbene ruthenium compound with anticancer activity and a preparation method and application thereof. The pyrazole functionalized n-heterocyclic carbene ruthenium compound is prepared by using 5-methyl-1-hydrogen-pyrazole ethyl formate through alkylation, reduction, chlorination, salt formation and metal exchange reaction, and the general formula of the pyrazole functionalized n-heterocyclic carbene ruthenium compound is [LRu(p-cymene)Cl](X) (L=pyrazole functionalized n-heterocyclic carbene ligand, and X is anions). In the cytotoxicity test of breast cancer cells (Bcap-37), intestinal cancer cells (LoVo), gastric cancer cells (SCG7901) and cisplatin-resistant gastric cancer cells (SCG7901-R), the n-heterocyclic carbene ruthenium compound can effectively inhibit cancer cell division and reproduction. The n-heterocyclic carbene ruthenium compound is variable in structure, convenient to synthesize, stable in performance, environmentally friendly, capable of stably existing in air for a long time, and promising in application prospect of pharmaceutical industry and fine chemical engineering industry.